stockrow
Friday 6 November 2026
Export STE’s income statement to Excel — free account
STERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.
- Revenue
- +8.79%
- EPS
- +12.8%
- Free cash flow
- +43.6%
- Total debt
- −0.21%
Quarter to September 2026, against a year earlier
252.80
1.32
−0.52%
Follow STE
Alert me
STERIS plc (STE) EBITDA
STERIS plc's EBITDA for fiscal 2026 was $1.6B, up 18.3% from $1.3B in fiscal 2025. Over the twelve months to 30 September 2026 it was $1.7B. Over the past ten years it has ranged from $318.8M (fiscal 2015) to $1.6B (fiscal 2026) — the current reading is the highest in ten years. STERIS plc ranks 9th of 147 Medical Devices companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2026 | $1.6B | 18.28% |
| FY2025 | $1.3B | (4.50%) |
| FY2024 | $1.4B | 4.05% |
| FY2023 | $1.4B | 23.12% |
| FY2022 | $1.1B | 42.99% |
| FY2021 | $767.6M | 4.54% |
| FY2020 | $734.3M | 15.28% |
| FY2019 | $636.9M | 10.16% |
| FY2018 | $578.2M | 22.32% |
| FY2017 | $472.7M | 32.53% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $419.9M | 2.49% |
| Jun 2026 | $409.7M | (6.91%) |
| Mar 2026 | $440.1M | 11.33% |
| Dec 2025 | $395.3M | 2.01% |
| 43 more quarters | Free account |
Against its own ten years
Low $318.8M
High $1.6B
Ten-year median
$750.9M
Current reading's percentile
100
EBITDA against peers
| Company | EBITDA |
|---|---|
| GEHC GE HealthCare Technologies Inc. compare | $3.5B |
| PHG Koninklijke Philips N.V. compare | $3.1B |
| SNN Smith & Nephew SNATS, Inc. compare | $2.6B |
| ZBH Zimmer Biomet Holdings, Inc. compare | $2.3B |
| STE STERIS plc | $1.7B |
| DXCM DexCom, Inc. compare | $1.5B |
| GMED Globus Medical, Inc. compare | $932.9M |
| PEN Penumbra, Inc. compare | $209.4M |
| GKOS Glaukos Corporation compare | −$130.8M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on STE
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement